top of page
-
Multi-disciplinary team of development professionals with 10 successful product launches in the infectious disease space
-
Instrumental in advancing the first successful Ebola vaccine towards licensure
-
Focused on accelerating development of biological products against infectious diseases and cancer
-
We offer companies an alternative to hiring or diverting costly personnel to the development of a pipeline product by providing an external development team
-
This approach allows corporations flexible use of their resources, minimizes capital investment, and enhances return on investment
-
Crozet’s customers include public and private biopharmaceutical companies and non-profit organizations
bottom of page